137 related articles for article (PubMed ID: 38631288)
41. Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.
Harders SW; Madsen HH; Hjorthaug K; Arveschoug AK; Rasmussen TR; Meldgaard P; Hoejbjerg JA; Pilegaard HK; Hager H; Rehling M; Rasmussen F
Cancer Imaging; 2014 Jun; 14(1):23. PubMed ID: 25608616
[TBL] [Abstract][Full Text] [Related]
42. Prognostic and Predictive Values of Metabolic Parameters of
Li X; Wang D; Yu L
Mol Imaging; 2019; 18():1536012119846025. PubMed ID: 31144578
[TBL] [Abstract][Full Text] [Related]
43. Virtual bronchoscopy using FDG-PET/CT images for the evaluation of lung cancer.
Yildirim D; Tamam M; Sanli Y; Ozgul MA; Somay A
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1951-60. PubMed ID: 23242722
[TBL] [Abstract][Full Text] [Related]
44. Differentiation of lung neoplasms with lepidic growth and good prognosis from those with poor prognosis using computer-aided 3D volumetric CT analysis and FDG-PET.
Morimoto D; Takashima S; Sakashita N; Sato Y; Jiang B; Hakucho T; Miyake C; Takahashi Y; Tomita Y; Nakanishi K; Hosoki T; Higashiyama M
Acta Radiol; 2014 Jun; 55(5):563-9. PubMed ID: 24003260
[TBL] [Abstract][Full Text] [Related]
45. Artificial Intelligence in Breast Cancer: A Systematic Review on PET Imaging Clinical Applications.
Alongi P; Rovera G; Stracuzzi F; Popescu CE; Minutoli F; Arnone G; Baldari S; Deandreis D; Caobelli F
Curr Med Imaging; 2023; 19(8):832-843. PubMed ID: 36703586
[TBL] [Abstract][Full Text] [Related]
46. PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohort.
Brose A; Michalski K; Ruf J; Tosch M; Eschmann SM; Schreckenberger M; König J; Nestle U; Miederer M
Cancer Imaging; 2023 May; 23(1):45. PubMed ID: 37198668
[TBL] [Abstract][Full Text] [Related]
47. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
[TBL] [Abstract][Full Text] [Related]
48. Role of 2-[18F]fluoro-2-deoxyglucose positron emission tomography in preoperative management of solid-type small-sized lung cancer.
Saisho S; Yasuda K; Maeda A; Yukawa T; Okita R; Hirami Y; Shimizu K; Nakata M
Ann Nucl Med; 2013 Jul; 27(6):515-22. PubMed ID: 23504519
[TBL] [Abstract][Full Text] [Related]
49. [Clinical value of PET/CT for the diagnosis and management of lung nodules].
Dang YP; Liu G; Wang H; Li M
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):685-7. PubMed ID: 15777509
[TBL] [Abstract][Full Text] [Related]
50. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
[TBL] [Abstract][Full Text] [Related]
51. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.
Mac Manus MP; Hicks RJ; Matthews JP; McKenzie A; Rischin D; Salminen EK; Ball DL
J Clin Oncol; 2003 Apr; 21(7):1285-92. PubMed ID: 12663716
[TBL] [Abstract][Full Text] [Related]
52. Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis.
Quanyang W; Yao H; Sicong W; Linlin Q; Zewei Z; Donghui H; Hongjia L; Shijun Z
Cancer Med; 2024 Apr; 13(7):e7140. PubMed ID: 38581113
[TBL] [Abstract][Full Text] [Related]
53. Pseudomesotheliomatous lung cancer mimicking mesothelioma on ¹⁸F-FDG PET/CT images: report of 2 cases.
Nakamori T; Kosuda S; Kyoto Y; Fujikawa A; Naoi Y; Nakamori Y
Jpn J Radiol; 2013 Aug; 31(8):542-5. PubMed ID: 23620108
[TBL] [Abstract][Full Text] [Related]
54. Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
Li M; Peng Z; Liu Q; Sun J; Yao S; Liu Q
Oncol Rep; 2013 Jan; 29(1):205-11. PubMed ID: 23124523
[TBL] [Abstract][Full Text] [Related]
55. Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.
Homann G; Mustafa DF; Ditt H; Spengler W; Kopp HG; Nikolaou K; Horger M
Acad Radiol; 2015 Apr; 22(4):505-12. PubMed ID: 25586709
[TBL] [Abstract][Full Text] [Related]
56. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
[TBL] [Abstract][Full Text] [Related]
57. Artificial intelligence enables whole-body positron emission tomography scans with minimal radiation exposure.
Wang YJ; Baratto L; Hawk KE; Theruvath AJ; Pribnow A; Thakor AS; Gatidis S; Lu R; Gummidipundi SE; Garcia-Diaz J; Rubin D; Daldrup-Link HE
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2771-2781. PubMed ID: 33527176
[TBL] [Abstract][Full Text] [Related]
58. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
59.
Girum KB; Rebaud L; Cottereau AS; Meignan M; Clerc J; Vercellino L; Casasnovas O; Morschhauser F; Thieblemont C; Buvat I
J Nucl Med; 2022 Dec; 63(12):1925-1932. PubMed ID: 35710733
[TBL] [Abstract][Full Text] [Related]
60. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
